Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACCORD
NCT00000620Phase 3Completed
- Sponsor
- National Heart, Lung, and Blood Institute
- Start
- Sep 1999
- Primary completion
- Jun 2009
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of fenofibrate in type 2 diabetes mellitus (T2DM), cardiovascular diseases (CVD), sponsored by National Heart, Lung, and Blood Institute. Started Sep 1999; status: completed.
02
Drugs
fenofibrate
03
Conditions
type 2 diabetes mellitus (T2DM)cardiovascular diseases (CVD)
Beyond the preview
Go deeper on NCT00000620.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00000620.